WASHINGTON, D.C.— The U.S. Supreme Court, by a 7-2 vote, rejected the Trump administration's request to immediately implement new restrictions on treatments and support for transgender people incarcerated in federal prisons.
The decision, issued on October 21, 2026, upholds a lower
court injunction preventing the implementation of these restrictions while
litigation continues. The only justices who dissented were Clarence Thomas and
Samuel Alito.
Among the measures the administration sought to implement
were the suspension of hormone treatments, the prohibition of certain surgical
procedures, and the removal of items such as wigs and makeup provided under
previous policies, all paid for with taxpayer funds.
The Trump administration maintains that these changes
reflect its views on healthcare in prisons and institutional security
considerations. However, the inmates, as expected, challenged the measure,
arguing that withdrawing medically necessary treatments could violate their
constitutional rights.
The Court's ruling does not represent a final judgment on
the merits of the case, nor does it mean that the judges have permanently mandated
the continuation of all these services. For now, the previous provisions remain
in effect while the courts examine the controversy.
The dispute continues in the courts, and the outcome will
determine the extent to which taxpayer money can be used to cater to
incarcerated transgender individuals.